EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Effects of Sarpogrelate Versus Aspirin on Whole Blood Viscosity in Patients With Type 2 Diabetes and Peripheral Artery Disease

Fatima Nari, Jooyeop Lee iD, Joohee Kim, Soo Lim iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71265 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Fatima Nari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Succinates, Aspirin, Blood Viscosity. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Daewoong Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whole blood viscosity (WBV) is associated with impaired microvascular circulation and cardiovascular risk in patients with Type 2 diabetes mellitus (T2DM) and peripheral artery disease (PAD). This study investigated the efficacy and safety of sarpogrelate compared with aspirin on WBV in patients with T2DM and PAD.

Methods

This randomised, open‐label clinical trial enrolled adults with T2DM and PAD. A total of 66 participants were randomised to aspirin ( n = 33) or sarpogrelate ( n = 33) for 24 weeks. The primary endpoint was change in diastolic WBV at a shear rate of 1 s −1 from baseline to week 24. Secondary endpoints included tissue oxygen delivery index, pain visual analogue scale (VAS) and cold sensation scores.

Results

After 24 weeks, diastolic WBV did not decrease significantly in both groups (sarpogrelate group: 31.91 ± 7.83 to 30.76 ± 7.08, mean change, −1.15 ± 9.25; p = 0.509; aspirin group: 33.32 ± 8.86 to 32.12 ± 9.60, mean change, −1.20 ± 8.36; p = 0.432). VAS scores improved significantly in both groups (mean change, −9.09 ± 18.09; p = 0.007 for sarpogrelate; −6.13 ± 16.47; p = 0.047 for aspirin), with no between‐group difference. Cold sensation scores improved only in the sarpogrelate group (mean change, −0.21 ± 0.55; p = 0.033 vs. −0.23 ± 0.85; p = 0.147 for aspirin group), with no between‐group difference.

Conclusion

In patients with T2DM and PAD, sarpogrelate did not significantly improve WBV compared with aspirin. VAS scores and cold sensation improved significantly within the sarpogrelate group with no between‐group difference.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2SuccinatesAspirinBlood ViscosityPeripheral Arterial DiseaseDiabetic AngiopathiesPlatelet Aggregation InhibitorsHumansFemaleMaleMiddle AgedAgedTreatment Outcome

Stichwörter der Autor:innen

5‐HT2A receptoraspirinperipheral artery diseasesarpogrelatetype 2 diabetes mellituswhole blood viscosity

Substanzen

sarpogrelateSuccinatesAspirinPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Jooyeop Lee, Soo Lim

Förderung

  • Daewoong Pharmaceutical Company

Zitieren

APA

Nari, F., Lee, J., Kim, J., & Lim, S. (2026). Effects of Sarpogrelate Versus Aspirin on Whole Blood Viscosity in Patients With Type 2 Diabetes and Peripheral Artery Disease. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71265

Vancouver

Nari F, Lee J, Kim J, Lim S. Effects of Sarpogrelate Versus Aspirin on Whole Blood Viscosity in Patients With Type 2 Diabetes and Peripheral Artery Disease. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71265

BibTeX
@article{Nari2026,
  author = {Nari, Fatima and Lee, Jooyeop and Kim, Joohee and Lim, Soo},
  title = {Effects of Sarpogrelate Versus Aspirin on Whole Blood Viscosity in Patients With Type 2 Diabetes and Peripheral Artery Disease},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71265}
}
Kostenlos starten →